Our findings suggest that bone marrow, adipose tissue and dental pulp may serve as a universal donor MSC source for the prevention of burn wound progression.
Objective
The aim of our study was to investigate the effect of Transforming growth factor beta-1 (TGF-
β
1) gene therapy on the surface markers, multilineage differentiation, viability, apoptosis, cell cycle, DNA damage and senescence of human Dental Pulp-derived Mesenchymal Stromal Cells (hDPSC).
Methods
hDPSCs were isolated from human teeth, and were cultured with 20% Fetal Bovine Serum (FBS) in minimum essential media-alpha (
α
-MEM). TGF-
β
1 gene transfer into hDPSCs was performed by electroporation method after the plasmid was prepared. The transfection efficiency was achieved by using western blot and flow cytometry analyses and GFP transfection. Mesenchymal stem cell (MSC) markers, multilineage differentiation, cell proliferation, apoptosis, cell cycle, DNA damage and cellular senescence assays were performed by comparing the transfected and non-transfected cells. Statistical analyses were performed using GraphPad Prism.
Results
Strong expression of TGF-
β
1 in pCMV-TGF-
β
1-transfected hDPSCs was detected in flow cytometry analysis. TGF-
β
1 transfection efficiency was measured as 95%. Western blot analysis showed that TGF-
β
1 protein levels increased at third and sixth days in pCMV-TGF-
β
1-transfected hDPSCs. The continuous TGF-
β
1 overexpression in hDPSCs did not influence the immunophenotype and surface marker expression of MSCs. Our results showed that TGF-
β
1 increased osteogenic and chondrogenic differentiation, but decreased adipogenic differentiation. Overexpression of TGF-
β
1 increased the proliferation rate and decreased total apoptosis in hDPSCs (p<0.05). The number of cells at “
S
” phase was higher with TGF-
β
1 transfection (p<0.05). Cellular senescence decreased in TGF-
β
1 transfected group (p<0.05).
Conclusions
These results reflect that TGF-
β
1 has major impact on MSC differentiation. TGF-
β
1 transfection has positive effect on proliferation, cell cycle, and prevents cellular senescence and apoptosis.
Purpose:
The aim of this study is to compare effects of postoperative care agents;
chlorhexidine, octenidine dihydrochloride and hyaluronic acid on human gingival
fibroblasts’ viability, proliferation, apoptosis and migration.
Materials and methods:
After cell culturing; chlorhexidine, octenidine dihydrochloride and hyaluronic acid
solutions were applied on cells and nothing was applied for control group. The cells
were monitored to investigate cytotoxicity; the percentage of apoptotic, living and
dead cells at the time of 24, 48, and 72 hours (h). A scratch wound assay was performed
to detect cell migration and cells were monitored at baseline, at 24 and 48h.
Results:
At 24h, chlorhexidine showed statistically lower percentage of total apoptotic
cells’ than octenidine dihydrochloride (p=0.049), hyaluronic acid (p=0.049) and
control (p=0.049). At 48h, hyaluronic acid showed statistically lower percentage
than chlorhexidine (p=0.049), and control (p=0.049). All agents were found to
have statistically and significantly more cytotoxic than control. However, there
was no difference between experimental groups for proliferation rate. Octenidine
dihydrochloride showed statistically negative effects on cell migration than
chlorhexidine and hyaluronic acid at 24h. Chlorhexidine and hyaluronic acid
maintained migration ability of cells than octenidine dihydrochloride at 48h.
Conclusion:
All agents have similar effects on cell behavior such as viability, apoptosis and cell
proliferation. However, octenidine dihydrochloride showed statistically negative
effects on migration ability than chlorhexidine and hyaluronic acid.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.